Status:
COMPLETED
Impact of Pharmacist-led Educational Intervention on Pneumococcal Vaccination Rates in Cancer Patients
Lead Sponsor:
Hacettepe University
Conditions:
Pneumonia, Bacterial
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
According to the World Health Organization (WHO), immunization; is defined as making a person immune or resistant to an infectious disease by applying a vaccine (1). The primary indicator of an effect...
Eligibility Criteria
Inclusion
- The study will involve patients who have all of the following features simultaneously.
- patients who visit medical oncology outpatient clinics,
- patients who are over 18 years old,
- patients who have been diagnosed with cancer for less than two years,
- patients who are in remission stage (as determined by a medical oncologist),
- patients who have never had the pneumococcal vaccine.
Exclusion
- patients who could not communicate in Turkish,
- patients who were illiterate,
- patients who had visual/auditory/cognitive impairments,
- patients who had previously received a pneumococcal vaccine recommendation,
- patients who did not know their pneumococcal immunization status
- patients who want to leave the study
Key Trial Info
Start Date :
July 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2021
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT05229081
Start Date
July 19 2019
End Date
February 15 2021
Last Update
February 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University Faculty of Medicine Department of Medical Oncology
Ankara, Turkey (Türkiye), 06100